A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Pediatric allergy and immunology 30.2019, (5), S. 553-561, doi: 10.1111/pai.13060
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
-
Aygören‐Pürsün, Emel
Soteres, Daniel F.
Nieto‐Martinez, Sandra A.
Christensen, Jim
Jacobson, Kraig W.
Moldovan, Dumitru
Leerberghe, Arthur van
Tang, Yongqiang
Lu, Peng
Vardi, Moshe
Schranz, Jennifer
Martinez‐Saguer, Inmaculada
- URN
-
urn:nbn:de:hebis:30:3-529040
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aygören‐Pürsün, Emel
- Soteres, Daniel F.
- Nieto‐Martinez, Sandra A.
- Christensen, Jim
- Jacobson, Kraig W.
- Moldovan, Dumitru
- Leerberghe, Arthur van
- Tang, Yongqiang
- Lu, Peng
- Vardi, Moshe
- Schranz, Jennifer
- Martinez‐Saguer, Inmaculada
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial : the OPuS‐2 study
"Prophylaxis"
Prophylaxis.
Prophylaxis
Subcutaneous C1-Inhibitor concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
II. Prophylaxis
Liposomal inhalation after tracheostomy - a randomized controlled trial
Problems of subgroup analysis in randomized controlled trial
Hereditary nephritis
Prophylaxis des Kindbettfiebers.
Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial : the OPuS‐2 study
"Prophylaxis"
Prophylaxis.
Prophylaxis
Subcutaneous C1-Inhibitor concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
II. Prophylaxis
Liposomal inhalation after tracheostomy - a randomized controlled trial
Problems of subgroup analysis in randomized controlled trial
Hereditary nephritis
Prophylaxis des Kindbettfiebers.
Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial : the OPuS‐2 study
"Prophylaxis"
Prophylaxis.
Prophylaxis
Subcutaneous C1-Inhibitor concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
II. Prophylaxis
Liposomal inhalation after tracheostomy - a randomized controlled trial
Problems of subgroup analysis in randomized controlled trial
Hereditary nephritis
Prophylaxis des Kindbettfiebers.